You are here

Immuno-mycologics, Inc.

Company Information
Address
2701 CORPORATE CENTER DR
NORMAN, OK 73069-2901
United States



Information

DUNS: 099550915

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. DEVELOPMENT AN EASY-TO-USE DIAGNOSTIC TEST CAPABLE OF EARLY, RAPID DETECTION OF TALAROMYCES ANTIGEN IN HUMAN SERUM, PLASMA, AND/OR URINE.

    Amount: $299,593.00

    Talaromycosis is caused by the dimorphic fungus Talaromyces (formerly Penicillium) marneffei endemic in Southeast Asia. In just over two decades, the HIV epidemic has transformed talaromycosis from a ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  2. Lateral Flow Assay for Diagnosis of Histoplasmosis

    Amount: $1,819,658.00

    DESCRIPTION provided by applicant Progressive disseminated histoplasmosis is a common and serious opportunistic infection among individuals with HIV AIDS In many resource limited areas such as La ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  3. Fluorescent Lateral Flow Assay for Diagnosis of Cocciodioidomycosis

    Amount: $150,000.00

    Coccidioidomycosis, also known as Valley Fever, is a disease caused by inhalation of Coccidioides arthroconidia. This disease is endemic to the southwestern United States, parts of Mexico, and Centra ...

    SBIRPhase I2014Department of Health and Human Services Centers for Disease Control and Prevention
  4. Rabbit InMAD Discovery of Novel Biomarkers for POC Tuberculosis Diagnostic Assay

    Amount: $592,540.00

    DESCRIPTION provided by applicant Tuberculosis TB is a chronic infectious disease that infects approximately one third of the worldandapos s population Eighty five percent of the estimated m ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
  5. Immunoassay for diagnosis of invasive fungal disease

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Early diagnosis of infectious disease is critical to patient outcome. An important early question is - is it a fungus, a bacterium or a virus? A rapid answer to ...

    STTRPhase I2013Department of Health and Human Services National Institutes of Health
  6. Flow Cytometry Assay for Detection of Cryptococcal Antigen

    Amount: $493,861.00

    Cryptococcal meningitis (CM) kills more than 600,000 HIV-infected individuals globally per year, with the highest yearly incidence occurring in sub-Saharan Africa. There is a critical need for a simpl ...

    SBIRPhase II2013Department of Health and Human Services Centers for Disease Control and Prevention
  7. Antigen Immunoassay for Diagnosis of Coccidioidomycosis

    Amount: $586,503.00

    DESCRIPTION (provided by applicant): Coccidioidomycosis, also known as Valley Fever, is a fungal disease caused by Coccidioides spp. that infects an estimated 150,000 people each year in the Unite ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  8. Point-of-care immunoassay for diagnosis of cryptococcosis in HIV/AIDS from whole blood

    Amount: $149,891.00

    Cryptococcal meningitis (CM) kills more than 600,000 HIV-infected individuals globally per year, with the highest yearly incidence occurring in sub-Saharan Africa. There is a critical need for a simpl ...

    SBIRPhase I2012Department of Health and Human Services Centers for Disease Control and Prevention
  9. Point-of-care immunoassay for diagnosis of histoplasmosis in HIV/AIDS

    Amount: $588,749.00

    DESCRIPTION (provided by applicant): Progressive disseminated histoplasmosis is a common and life-threatening fungal infection among patients with HIV/AIDS in the United States and Latin America. Inc ...

    STTRPhase I2011Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government